Risk factors associated with contamination of allograft valves in a tissue bank
The contamination of the transport solution used in cardiovascular allografts can occur from different sources. Risk factors associated with positive microbiological test of transport solution have not been reported previously. This study aimed to determine the risk factor for contamination of transport solution used in the heart valve allografts stored in a Brazilian tissue bank. This retrospective study was conducted on all donors of cardiovascular allografts stored in a tissue bank from December 2008 to December 2017. Microbiological cultures for aerobic and anaerobic bacteria, fungi/yeasts were carried out in TS. Clinical variables were included. From 1001 transport solution, 52% were contaminated. A total of 770 microorganisms were identified, and Staphylococcus spp. was identified in 248 isolates (32.2%). Skin bacteria from skin microbiota were the most commonly identified microorganisms (Staphylococcus spp., Cutibacterium spp., Corynebacterium spp., and Bacillus spp.), occurring in 49.6%. The presence of a diagnosis of healthcare-associated infection was not associated with skin contamination (odds ratio [OR] 0.62 [0.41–0.94]; p = 0.014). Conditions like fever, use of antibiotics, and leukocytosis were less likely associated with contamination of transport solution. A longer warm ischemic time was associated with higher frequency of contamination. In the multivariable analysis, warm ischemic time was independently associated with contamination, and antibiotic therapy was a factor that decreased the rate of contamination (p < 0.05). Contamination of transport solution is associated with modifiable risk factors, such as warm ischemic time. Measures to minimize contamination should be employed to avoid unnecessary tissue discharges.
KeywordsAllografts Microbiology Risk factors Tissue banking
Compliance with ethical standards
Conflict of interest
Authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.
- ANVISA (2015) Boas Práticas em Tecidos humanos para uso terapêutico. Resolução RDC n55Google Scholar
- Centers for Disease, C., & Prevention (2002) Update: allograft-associated bacterial infections–United States, 2002. MMWR Morb Mortal Wkly Rep 51(10):207–210Google Scholar
- ECOT (2016) Guide to the quality and safety of organs for transplantation, 6th edn. European Committee on Organ TransplantationGoogle Scholar
- Germain M, Strong DM, Dowling G, Mohr J, Duong A, Garibaldi A, Cardiac Tissue Working g (2016) Disinfection of human cardiac valve allografts in tissue banking: systematic review report. Cell Tissue Bank 17(4):593–601. https://doi.org/10.1007/s10561-016-9570-9 CrossRefPubMedPubMedCentralGoogle Scholar
- Jashari R, Tabaku M, Van Hoeck B, Cochez C, Callant M, Vanderkelen A (2007) Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions. Cell Tissue Bank 8(4):247–255. https://doi.org/10.1007/s10561-007-9040-5 CrossRefGoogle Scholar
- Kowalski JB, Merritt K, Gocke D, Osborne J (2012a) Assessment of bioburden on human and animal tissues: part 2–results of testing of human tissue and qualification of a composite sample for routine bioburden determination. Cell Tissue Bank 13(3):431–439. https://doi.org/10.1007/s10561-012-9296-2 CrossRefPubMedGoogle Scholar
- Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Hosts ESG, ESCMID Study Group of Infection in Compromised Hosts (ESGICH) (2014) Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 20(Suppl 7):10–18. https://doi.org/10.1111/1469-0691.12557 CrossRefPubMedGoogle Scholar
- Paolin A, Trojan D, Petit P, Coato P, Rigoli R (2017) Evaluation of allograft contamination and decontamination at the Treviso Tissue Bank Foundation: a retrospective study of 11,129 tissues. PLoS ONE 12(3):e0173154. https://doi.org/10.1371/journal.pone.0173154 CrossRefPubMedPubMedCentralGoogle Scholar
- Tabaku M, Jashari R, Carton HF, Du Verger A, Van Hoeck B, Vanderkelen A (2004) Processing of cardiovascular allografts: effectiveness of European Homograft Bank (EHB) antimicrobial treatment (cool decontamination protocol with low concentration of antibiotics). Cell Tissue Bank 5(4):261–266. https://doi.org/10.1007/s10561-004-1440-1 CrossRefPubMedGoogle Scholar
- WHO (2003) Consultation on the ethic. Access and safety in tissue and organ transplantation: issues of global concern. Retrieved from Madrid, SpainGoogle Scholar